Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Febuxostat vs Allopurinol Cardiovascular Safety in Gout (CARES)
NCT01101035Phase 3Completed
- Sponsor
- Takeda
- Start
- Apr 2010
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of febuxostat in gout, sponsored by Takeda. Started Apr 2010; status: completed.
02
Drugs
febuxostat
03
Conditions
gout
Beyond the preview
Go deeper on NCT01101035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01101035.